Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin

Transplantation

Volumn 64, Issue 12, 1997, Pages 1847-1850

  Moudgil, Asha ^a,b   Shidban, Hamid ^a   Nast, Cynthia C ^a   Bagga, Arvind ^a   Aswad, Saleh ^a   Graham, Stephen L ^a   Mendez, Robert ^a   Jordan, Stanley C ^a  

^a National Institute of Transplantation Los Angeles   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ANEMIA; CASE REPORT; CONFERENCE PAPER; ERYTHROCYTE APLASIA; FEMALE; GLOMERULOPATHY; GRAFT FAILURE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTION; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; ANEMIA; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 0031450626     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00037     Document Type: Conference Paper

References (12)

1. Anderson MJ. Parvoviruses. In: Velshe RB, ed. Textbook of human virology, 2nd ed. St. Louis: Mosby Year Book 1991: 1012.
2. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle cell anemia. Lancet 1981; 1: 664.
3. Rao KRP, Parel AR, Anderson MJ, et al. Infection with a parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med 1983; 98: 930.
4. Strum I, Watschinger B, Geissler K, et al. Chronic parvovirus B19 infection-associated pure red cell anemia in a kidney transplant recipient. Nephrol Dial Transplant 1996; 11: 1367.
5. Ndimbie OK, Frezza E, Jordan JA, Koch W, Thiel DH. Parvovirus B19 in anemic liver transplant recipients. Clin Diag Lab Immunol 1996; 3: 756.
6. Frickhofen N, Abcowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1); a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926.
7. Corbett TJ, Saw H, Popat U, et al. Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant. Bone Marrow Transplant 1995; 16: 711.
8. Wierenga KJ, Pattison JR, Brink N, et al. Glomerulonephritis after human parvovirus infection in homozygous sickle cell disease. Lancet 1995; 346: 475.
9. Corral DA, Darras FS, Jensen CW, et al. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. Transplantation 1993; 55: 4227.
10. Bowman CA, Cohen BJ, Norfolk DR, Lacy CJN. Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin [Letter]. AIDS 1990; 4: 1038.
11. Markenson AL, Chandra M, Lewy JE, Miller DR. Sickle cell anemia, the nephrotic syndrome and hypoplastic crisis in a sibship. Am J Med 1978; 64: 719.
12. Cooling LLW, Koerner TAW, Naides SJ. Multiple glycosphingo-lipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995; 172: 1198.